| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/21/1998 | US5741785 Imidazolo(1,2-a)quinoxalinone compounds; antiischemic agents; nervous system disorders |
| 04/21/1998 | US5741773 Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741487 Mutanase-containing oral compositions |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015535A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/15/1998 | EP0835658A2 Enhancing and stabilizing agent of the activity of bifidus factor |
| 04/15/1998 | EP0835318A2 Vaccines against hepatitis c |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835251A1 Process for the production of lipoic acid |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0650331B1 Food products containing benzimidazole |
| 04/15/1998 | CN1179162A Heterocycle-fused thiazole derivatives |
| 04/15/1998 | CN1179158A 4 -amino -3 -acylnaphthyridine derivatives |
| 04/15/1998 | CN1178702A Chinese herbal medicine powder for curing hepatitis B |
| 04/14/1998 | US5739351 Neurokinin a antagonists |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent |
| 04/14/1998 | US5739164 Block metabotropic glutamate receptors |
| 04/14/1998 | US5739162 Antagonist for gastrin and/or cholecystokinin b-not a-receptors; side effect reduction; antiulcer agents; opiod-enhancing analgesics; gastrointestinal disorders; anxiolytic agents |
| 04/14/1998 | US5739151 Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 04/14/1998 | US5739148 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 04/14/1998 | US5739147 Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739134 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran, dihydrobenzodioxin, benzodioxole, dihydrobenzodioxepin, or tetrahydrobenzoxepin)carboxamide derivatives |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739002 Providing reaction mixture comprising ns3 protease and substrate, adding candidate compound comprising fragment of hepatitis c virus ns4a protein, measuring protease activity to determine whether increase has occurred |
| 04/14/1998 | CA1339819C 2-(pyrid-2-yl) methylthio (or methylsulfinyl)- benzimidazole derivativestheir production and use |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014198A1 Methods and compositions for preventing and treating heartburn |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014177A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267340A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833823A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833668A1 Inhibition of hepatitis b replication |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833644A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 04/08/1998 | EP0833634A1 Use of n-cyclohexyl benzamides for treating bowel disorders |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0715624B1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | EP0623021B1 4''-deoxyerythromycin derivatives |
| 04/08/1998 | CN1178532A Tricyclic vasopressin antagonists |
| 04/08/1998 | CN1178111A Weijisan for gastropathy |
| 04/08/1998 | CN1178108A Weixiandan as medicine for gastropathy |
| 04/07/1998 | US5736562 Modify function of serotonin in mammals |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | CA2146259C Substituted benzylaminoquinuclidines |
| 04/07/1998 | CA2003441C Quinuclidine therapeutic agents |
| 04/07/1998 | CA1339802C Diarylstrylquinoline diacids |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 04/02/1998 | WO1998013349A2 Heteroaryloxyethylamines as 5-ht1a ligands |
| 04/02/1998 | WO1998013337A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 04/02/1998 | WO1998013065A1 Rotavirus vaccine formulations |
| 04/02/1998 | WO1998013056A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2266929A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/01/1998 | EP0832887A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832266A1 Oral delivery of adeno-associated viral vectors |
| 04/01/1998 | EP0832194A1 Bile duct progenitor cells and methods of use |
| 04/01/1998 | EP0832186A1 Replacement therapy for dental caries |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831893A1 Regulation of cytokine synthesis and release |
| 04/01/1998 | EP0831892A1 Multimeric, recombinant urease vaccine |
| 04/01/1998 | EP0831856A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 04/01/1998 | EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
| 04/01/1998 | EP0831852A1 Nucleosides with anti-hepatitis b virus activity |
| 04/01/1998 | EP0831835A1 Method for treating anorexia |
| 04/01/1998 | EP0831822A1 Calcium channel antagonists |
| 04/01/1998 | EP0831821A1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 04/01/1998 | EP0831791A1 Delivery of drugs to the lower gi tract |
| 04/01/1998 | EP0831774A1 Oral dosage and method for treating painful conditions of the oral cavity |
| 04/01/1998 | EP0831771A2 Oral delivery of gene constructs |
| 04/01/1998 | EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 03/31/1998 | US5734012 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 03/31/1998 | US5733939 Fluorocarbons as anti-inflammatory agents |
| 03/31/1998 | US5733923 Secretory pancreatic phospholipase a2 |
| 03/31/1998 | US5733922 Imidazole derivative, pharmaceutically acceptable salt thereof, and anti-ulcer drug including such derivative or salt |
| 03/31/1998 | US5733901 Administering to treat skin and respiratory system disorders, inflammatory disorders of the bowel, and allergic rhinitis/conjunctivitis |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |